ABUS earnings
Arbutus Biopharma (ABUS) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
ABUS earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | -0.03 | -0.02 | -50.00% | $1.01M |
| Q1 2026 | May 13, 2026 | 0.87 | -0.03 | 3000.00% | $179.13M |
| Q4 2025 | Mar 23, 2026 | -0.01 | -0.04 | 71.47% | $1.05M |
| Q3 2025 | Nov 13, 2025 | -0.04 | -0.06 | 28.57% | $529.00K |
| Q2 2025 | Aug 6, 2025 | 0.01 | -0.02 | 150.00% | $10.74M |
| Q1 2025 | May 14, 2025 | -0.13 | -0.09 | -44.44% | $1.76M |
| Q4 2024 | Mar 27, 2025 | -0.07 | -0.08 | 12.50% | $1.57M |
| Q3 2024 | Nov 6, 2024 | -0.10 | -0.10 | 0.00% | $1.34M |
| Q2 2024 | Aug 1, 2024 | -0.11 | -0.10 | -10.00% | $1.73M |
| Q1 2024 | May 2, 2024 | -0.10 | -0.10 | 0.00% | $1.53M |
| Q4 2023 | Feb 29, 2024 | -0.12 | -0.12 | 0.00% | $2.15M |
| Q3 2023 | Nov 7, 2023 | -0.12 | -0.12 | 0.00% | $4.66M |
| Aug 3, 2023 | -0.10 | -0.12 | 16.67% | – | |
| May 4, 2023 | -0.10 | -0.14 | 28.57% | – | |
| Mar 2, 2023 | -0.14 | -0.14 | 0.00% | – | |
| Nov 9, 2022 | -0.12 | -0.12 | 0.00% | – | |
| Aug 4, 2022 | -0.10 | -0.13 | 23.08% | – | |
| May 5, 2022 | -0.11 | -0.13 | 15.38% | – | |
| Mar 3, 2022 | -0.15 | -0.16 | 6.25% | – | |
| Nov 4, 2021 | -0.24 | -0.24 | 0.00% | – |
- ABUS reports next on Nov 16, 2026, with EPS of -0.02 expected.
- ABUS beat EPS estimates in 42 of its last 66 reports.
Updated 2026-11-03 12:34 UTC